118 related articles for article (PubMed ID: 11875988)
1. Severe combined immunodeficiencies of the common gamma-chain/JAK3 signaling pathway.
Schumacher RF; Notarangelo LD
Isr Med Assoc J; 2002 Feb; 4(2):131-5. PubMed ID: 11875988
[No Abstract] [Full Text] [Related]
2. Human lung myofibroblasts as effectors of the inflammatory process: the common receptor gamma chain is induced by Th2 cytokines, and CD40 ligand is induced by lipopolysaccharide, thrombin and TNF-alpha.
Doucet C; Giron-Michel J; Canonica GW; Azzarone B
Eur J Immunol; 2002 Sep; 32(9):2437-49. PubMed ID: 12207328
[TBL] [Abstract][Full Text] [Related]
3. Jak3 and the pathogenesis of severe combined immunodeficiency.
O'Shea JJ; Husa M; Li D; Hofmann SR; Watford W; Roberts JL; Buckley RH; Changelian P; Candotti F
Mol Immunol; 2004 Jul; 41(6-7):727-37. PubMed ID: 15220007
[TBL] [Abstract][Full Text] [Related]
4. A partial deficiency of interleukin-7R alpha is sufficient to abrogate T-cell development and cause severe combined immunodeficiency.
Roifman CM; Zhang J; Chitayat D; Sharfe N
Blood; 2000 Oct; 96(8):2803-7. PubMed ID: 11023514
[TBL] [Abstract][Full Text] [Related]
5. A new modality for immunosuppression: targeting the JAK/STAT pathway.
O'Shea JJ; Pesu M; Borie DC; Changelian PS
Nat Rev Drug Discov; 2004 Jul; 3(7):555-64. PubMed ID: 15232577
[No Abstract] [Full Text] [Related]
6. Cytokine-mediated signalling and early defects in lymphoid development.
Giliani S; Mella P; Savoldi G; Mazzolari E
Curr Opin Allergy Clin Immunol; 2005 Dec; 5(6):519-24. PubMed ID: 16264332
[TBL] [Abstract][Full Text] [Related]
7. Severe combined immune deficiencies due to defects of the common gamma chain-JAK3 signaling pathway.
Candotti F; O'Shea JJ; Villa A
Springer Semin Immunopathol; 1998; 19(4):401-15. PubMed ID: 9618765
[No Abstract] [Full Text] [Related]
8. The role of Jak3 in lymphoid development, activation, and signaling.
Thomis DC; Berg LJ
Curr Opin Immunol; 1997 Aug; 9(4):541-7. PubMed ID: 9287175
[TBL] [Abstract][Full Text] [Related]
9. Jak3, severe combined immunodeficiency, and a new class of immunosuppressive drugs.
Pesu M; Candotti F; Husa M; Hofmann SR; Notarangelo LD; O'Shea JJ
Immunol Rev; 2005 Feb; 203():127-42. PubMed ID: 15661026
[TBL] [Abstract][Full Text] [Related]
10. Combined immunodeficiencies due to defects in signal transduction: defects of the gammac-JAK3 signaling pathway as a model.
Notarangelo LD; Giliani S; Mella P; Schumacher RF; Mazza C; Savoldi G; Rodriguez-Pérez C; Badolato R; Mazzolari E; Porta F; Candotti F; Ugazio AG
Immunobiology; 2000 Aug; 202(2):106-19. PubMed ID: 10993286
[TBL] [Abstract][Full Text] [Related]
11. Mutation of Jak3 in a patient with SCID: essential role of Jak3 in lymphoid development.
Russell SM; Tayebi N; Nakajima H; Riedy MC; Roberts JL; Aman MJ; Migone TS; Noguchi M; Markert ML; Buckley RH; O'Shea JJ; Leonard WJ
Science; 1995 Nov; 270(5237):797-800. PubMed ID: 7481768
[TBL] [Abstract][Full Text] [Related]
12. Mutations in the gene for the IL-7 receptor result in T(-)B(+)NK(+) severe combined immunodeficiency disease.
Puel A; Leonard WJ
Curr Opin Immunol; 2000 Aug; 12(4):468-73. PubMed ID: 10899029
[TBL] [Abstract][Full Text] [Related]
13. In vitro correction of JAK3-deficient severe combined immunodeficiency by retroviral-mediated gene transduction.
Candotti F; Oakes SA; Johnston JA; Notarangelo LD; O'Shea JJ; Blaese RM
J Exp Med; 1996 Jun; 183(6):2687-92. PubMed ID: 8676091
[TBL] [Abstract][Full Text] [Related]
14. A novel JAK3 mutation in a Japanese patient with severe combined immunodeficiency.
Uchiyama T; Kumaki S; Fujiwara M; Nishida Y; Hakozaki I; Imai K; Du W; Yoshinari M; Sasahara Y; Tsuchiya S
Pediatr Int; 2005 Oct; 47(5):575-8. PubMed ID: 16190968
[No Abstract] [Full Text] [Related]
15. Monocyte function in a severe combined immunodeficient patient with a donor splice site mutation in the Jak3 gene.
Villa A; Sironi M; Macchi P; Matteucci C; Notarangelo LD; Vezzoni P; Mantovani A
Blood; 1996 Aug; 88(3):817-23. PubMed ID: 8704236
[TBL] [Abstract][Full Text] [Related]
16. Autosomal SCID caused by a point mutation in the N-terminus of Jak3: mapping of the Jak3-receptor interaction domain.
Cacalano NA; Migone TS; Bazan F; Hanson EP; Chen M; Candotti F; O'Shea JJ; Johnston JA
EMBO J; 1999 Mar; 18(6):1549-58. PubMed ID: 10075926
[TBL] [Abstract][Full Text] [Related]
17. Impaired IL-7 signaling may explain a case of atypical JAK3-SCID.
Li J; Nara H; Rahman M; Juliana FM; Araki A; Asao H
Cytokine; 2010 Feb; 49(2):221-8. PubMed ID: 19889552
[TBL] [Abstract][Full Text] [Related]
18. Of genes and phenotypes: the immunological and molecular spectrum of combined immune deficiency. Defects of the gamma(c)-JAK3 signaling pathway as a model.
Notarangelo LD; Giliani S; Mazza C; Mella P; Savoldi G; Rodriguez-Pérez C; Mazzolari E; Fiorini M; Duse M; Plebani A; Ugazio AG; Vihinen M; Candotti F; Schumacher RF
Immunol Rev; 2000 Dec; 178():39-48. PubMed ID: 11213805
[TBL] [Abstract][Full Text] [Related]
19. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency.
Puel A; Ziegler SF; Buckley RH; Leonard WJ
Nat Genet; 1998 Dec; 20(4):394-7. PubMed ID: 9843216
[TBL] [Abstract][Full Text] [Related]
20. Molecular diagnosis of severe combined immunodeficiency--identification of IL2RG, JAK3, IL7R, DCLRE1C, RAG1, and RAG2 mutations in a cohort of Chinese and Southeast Asian children.
Lee PP; Chan KW; Chen TX; Jiang LP; Wang XC; Zeng HS; Chen XY; Liew WK; Chen J; Chu KM; Chan LL; Shek L; Lee AC; Yu HH; Li Q; Xu CG; Sultan-Ugdoracion G; Latiff ZA; Latiff AH; Jirapongsananuruk O; Ho MH; Lee TL; Yang XQ; Lau YL
J Clin Immunol; 2011 Apr; 31(2):281-96. PubMed ID: 21184155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
